Literature DB >> 2972577

Control of glucose metabolism in pancreatic beta-cells by glucokinase, hexokinase, and phosphofructokinase. Model study with cell lines derived from beta-cells.

T Shimizu1, J C Parker, H Najafi, F M Matschinsky.   

Abstract

Glucose usage by soluble fractions of cell extracts from two insulin-producing cell lines, RINm5F and HIT, was investigated. Analysis of enzyme activities indicated that glucose phosphorylation and phosphofructokinase are likely to be the rate-limiting steps of glycolysis in both RINm5F and HIT cell extracts. RINm5F extracts, which lack glucokinase, exhibited relatively flat concentration-dependency curves of glucose usage and showed substantial inhibition of hexokinase. HIT cell extracts, which contain glucokinase but lack hexokinase, exhibited sigmoidal concentration-dependency curves of glucose usage, reflecting almost fully expressed glucokinase activity. A reconstituted system prepared from RINm5F and HIT cell extracts exhibited a composite concentration-dependency curve of glucose usage and showed substantial inhibition of hexokinase and almost fully expressed glucokinase. However, conditions that activate phosphofructokinase, such as addition of ammonium sulfate or fructose 2,6-bisphosphate or alkalization, removed the inhibition of hexokinase without noticeably affecting the glucokinase component of usage. Results obtained with a reconstituted system containing RINm5F cell extract and purified glucokinase were consistent with these findings. The data presented here indicate that this reconstituted cell-free system serves as a valid model for the study of aspects of glycolytic control in the islet. This model illustrates the preeminent role of glucokinase in the control of glycolysis, consistent with its glucose-sensor function in the islet. In addition, these studies help to define the contribution of phosphofructokinase to the control of glycolysis and the mechanism whereby changes in phosphofructokinase activity could modulate, via changes in the glucose 6-phosphate concentration, the activity of hexokinase and hence the net glycolytic flux.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972577     DOI: 10.2337/diab.37.11.1524

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Oscillatory NAD(P)H waves and calcium oscillations in neutrophils? A modeling study of feasibility.

Authors:  Oliver Slaby; Dirk Lebiedz
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 2.  Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.

Authors:  F Matschinsky; Y Liang; P Kesavan; L Wang; P Froguel; G Velho; D Cohen; M A Permutt; Y Tanizawa; T L Jetton
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 3.  Type 1 diabetes and engineering enhanced islet transplantation.

Authors:  Abiramy Jeyagaran; Chuan-En Lu; Aline Zbinden; Andreas L Birkenfeld; Sara Y Brucker; Shannon L Layland
Journal:  Adv Drug Deliv Rev       Date:  2022-08-21       Impact factor: 17.873

4.  A model of phosphofructokinase and glycolytic oscillations in the pancreatic beta-cell.

Authors:  Pål O Westermark; Anders Lansner
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

5.  Ca2+ Effects on ATP Production and Consumption Have Regulatory Roles on Oscillatory Islet Activity.

Authors:  Joseph P McKenna; Joon Ha; Matthew J Merrins; Leslie S Satin; Arthur Sherman; Richard Bertram
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

6.  Mathematical analysis of a proposed mechanism for oscillatory insulin secretion in perifused HIT-15 cells.

Authors:  L W Maki; J Keizer
Journal:  Bull Math Biol       Date:  1995-07       Impact factor: 1.758

7.  Glucose Oscillations Can Activate an Endogenous Oscillator in Pancreatic Islets.

Authors:  Joseph P McKenna; Raghuram Dhumpa; Nikita Mukhitov; Michael G Roper; Richard Bertram
Journal:  PLoS Comput Biol       Date:  2016-10-27       Impact factor: 4.475

8.  Increased glucose metabolism and alpha-glucosidase inhibition in Cordyceps militaris water extract-treated HepG2 cells.

Authors:  Dae Jung Kim; Yun Hwan Kang; Kyoung Kon Kim; Tae Woo Kim; Jae Bong Park; Myeon Choe
Journal:  Nutr Res Pract       Date:  2017-05-22       Impact factor: 1.926

9.  Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity.

Authors:  Xinbin Zhao; Kun Sun; Zhou Lan; Wenxin Song; Lili Cheng; Wenna Chi; Jing Chen; Yi Huo; Lina Xu; Xiaohui Liu; Haiteng Deng; Julie A Siegenthaler; Ligong Chen
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 10.  Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical Options.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Healthcare (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.